N1-Methyl-lysergic acid diethylamide
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(8β)-N,N-Diethyl-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide | |
| Clinical data | |
| Routes of administration | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| CAS Number |
4238-85-1 |
| PubChem | CID 165200 |
| ChemSpider |
144824 |
| Synonyms | MLD-41, N1- Methyl- Lysergic Acid Diethylamide |
| Chemical data | |
| Formula | C21H27N3O |
| Molar mass | 337.47 g/mol |
| |
| |
| (verify) | |
N1-Methyl-lysergic acid diethylamide (MLD-41) is a derivative of LSD.
Metabolism of other 1-methylated-ergoloids to their secondary amine derivatives has been frequently noted in mammals.[1]
References
- ↑ Müller-Schweinitzer and Tapparelli (1986). Methylergometrine, an active metabolite of methysergide. Cephalalgia. 6: 35-41.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
